GlassScriptPhysician profile
Jason Dwayne Givan
NPI 1942254172
$3,309.87
in general payments reported to CMS, 2019-2025
22 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,177 · 2020: $116 · 2021: $310 · 2022: $451 · 2023: $449 · 2024: $530 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.97 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,740.71 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $353.18 | 2021-2025 | Ilumya, Blu-U |
| Novartis Pharmaceuticals Corporation | $277.03 | 2019-2024 | |
| Genentech USA, INC. | $218.19 | 2019 | |
| Lilly USA, LLC | $159.85 | 2019-2024 | Taltz, Olumiant |
| Genzyme Corporation | $84.64 | 2023-2025 | |
| Janssen Biotech, INC. | $80.23 | 2019-2025 | Tremfya |
| Pfizer INC. | $48.41 | 2021 | |
| Incyte Corporation | $46.64 | 2022-2024 | Opzelura |
| Ucb, INC. | $40.67 | 2019 | |
| Mission Pharmacal Company | $33.49 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $32.18 | 2022-2024 | Sotyktu |
| Amgen INC. | $28.06 | 2021 | |
| Galderma Laboratories, L.P. | $27.90 | 2020-2021 | |
| Almirall LLC | $24.55 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $23.24 | 2024 | Vtama |
| Biofrontera INC. | $17.36 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Celgene Corporation | $16.77 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.94 | 2022 | |
| Leo Pharma INC. | $15.71 | 2021 | |
| Merck Sharp & Dohme LLC | $12.80 | 2019 | |
| Kerecis Limited | $12.32 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Givan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.